DK1961420T3 - Middel til forebyggelse og behandling af akut nyresvigt - Google Patents
Middel til forebyggelse og behandling af akut nyresvigtInfo
- Publication number
- DK1961420T3 DK1961420T3 DK06834797.0T DK06834797T DK1961420T3 DK 1961420 T3 DK1961420 T3 DK 1961420T3 DK 06834797 T DK06834797 T DK 06834797T DK 1961420 T3 DK1961420 T3 DK 1961420T3
- Authority
- DK
- Denmark
- Prior art keywords
- prevention
- treatment
- kidney failure
- acute kidney
- acute
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005362579 | 2005-12-16 | ||
| PCT/JP2006/325054 WO2007069727A1 (ja) | 2005-12-16 | 2006-12-15 | 急性腎不全の予防または治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1961420T3 true DK1961420T3 (da) | 2012-08-27 |
Family
ID=38163029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06834797.0T DK1961420T3 (da) | 2005-12-16 | 2006-12-15 | Middel til forebyggelse og behandling af akut nyresvigt |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080319038A1 (da) |
| EP (1) | EP1961420B1 (da) |
| JP (1) | JP5107053B2 (da) |
| KR (1) | KR101350226B1 (da) |
| CN (1) | CN101325952B (da) |
| AU (1) | AU2006325947B2 (da) |
| CA (1) | CA2633481C (da) |
| DK (1) | DK1961420T3 (da) |
| ES (1) | ES2393271T3 (da) |
| HK (1) | HK1126123A1 (da) |
| PL (1) | PL1961420T3 (da) |
| WO (1) | WO2007069727A1 (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010038995A2 (ko) | 2008-10-02 | 2010-04-08 | 주식회사 엘지화학 | 광학 필름 및 이의 제조방법 |
| RU2012134639A (ru) | 2010-01-14 | 2014-02-20 | Санва Кагаку Кенкюсо Ко., Лтд. | Фармацевтический препарат для предупреждения и лечения нарушений, сопровождающихся глазным ангиогенезом и/или повышенной проницаемостью сосудов глаза |
| CA2791360A1 (en) | 2010-04-28 | 2011-11-03 | Sanwa Kagaku Kenkyusho Co., Ltd. | A pharmaceutical for preventing or treating an inner ear disorder |
| JP2015110525A (ja) * | 2012-04-02 | 2015-06-18 | 株式会社三和化学研究所 | 歯肉炎の予防又は治療のための医薬 |
| WO2016090373A1 (en) | 2014-12-05 | 2016-06-09 | Case Western Reserve University | Compositions and methods of modulating s-nitrosylation |
| US11426386B2 (en) | 2014-12-05 | 2022-08-30 | Case Western Reserve University | Compositions and methods of modulating S-nitrosylation |
| US11576900B2 (en) | 2017-09-25 | 2023-02-14 | Case Western Reserve University | Compositions and methods of reducing serum cholesterol and PCSK9 |
| WO2020005938A1 (en) | 2018-06-25 | 2020-01-02 | Case Western Reserve University | Compositions and methods for treating tissue injury |
| AU2019344066A1 (en) | 2018-09-21 | 2021-04-22 | Case Western Reserve University | Aldoketo reductase inhibitors and uses thereof |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61200991A (ja) | 1985-03-04 | 1986-09-05 | Sanwa Kagaku Kenkyusho:Kk | スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤 |
| EP0264586B1 (en) * | 1986-08-28 | 1991-04-03 | Sanwa Kagaku Kenkyusho Co., Ltd. | Hydantoin derivatives for treating complications of diabetes |
| US5164391A (en) * | 1989-09-20 | 1992-11-17 | Sanwa Kagaku Kenkyusho Co., Ltd. | Hydantoin derivatives for treating complications of diabetes and circulatory diseases |
| JP2997892B2 (ja) * | 1990-10-05 | 2000-01-11 | 株式会社三和化学研究所 | ヒダントイン誘導体を有効成分とする循環器系疾患の予防及び治療剤 |
| JP2997894B2 (ja) | 1990-11-07 | 2000-01-11 | 株式会社三和化学研究所 | 循環器系疾患の予防及び治療剤 |
| JP3267698B2 (ja) | 1992-10-27 | 2002-03-18 | 株式会社三和化学研究所 | ヒダントイン誘導体及びその塩並びにこれらを有効成分とするメイラード反応阻害剤 |
| JPH07242547A (ja) | 1994-03-02 | 1995-09-19 | Sanwa Kagaku Kenkyusho Co Ltd | 糖尿病性単純網膜症の進行阻止剤乃至治療剤 |
| JP3603129B2 (ja) | 1994-12-28 | 2004-12-22 | 株式会社三和化学研究所 | 糖尿病性角膜症の治療剤 |
| US6127367A (en) * | 1996-02-29 | 2000-10-03 | Pfizer, Inc. | Method of reducing tissue damage associated with non-cardiac ischemia |
| US6426341B1 (en) * | 1999-06-30 | 2002-07-30 | Pfizer Inc. | Treatment for diabetic complications |
| AU761191B2 (en) * | 2001-05-24 | 2003-05-29 | Pfizer Products Inc. | Therapies for tissue damage resulting from ischemia |
| WO2003013543A1 (en) | 2001-08-08 | 2003-02-20 | Genomed, Llc | Treatment or prevention of acute renal failure |
| TWI353979B (en) * | 2002-04-10 | 2011-12-11 | Nippon Zoki Pharmaceutical Co | Novel crystal form of 5-hydroxy-1-methylhydantoin |
| WO2003105864A1 (en) * | 2002-06-13 | 2003-12-24 | Board Of Regents, The University Of Texas System | Methods and compositions involving aldose reductase inhibitors |
| JP2004300153A (ja) * | 2003-03-20 | 2004-10-28 | Kiyoshi Kurokawa | 蛋白修飾物生成抑制剤 |
| JP5044122B2 (ja) * | 2003-10-24 | 2012-10-10 | 株式会社明治 | 後期糖化最終生成物形成の新規阻害剤及びアルドース還元酵素阻害剤 |
| JP4014053B2 (ja) * | 2004-01-30 | 2007-11-28 | 株式会社三和化学研究所 | 糖尿病黄斑症の予防又は治療剤 |
| JPWO2005079792A1 (ja) * | 2004-02-20 | 2008-09-18 | 株式会社三和化学研究所 | 重症糖尿病網膜症の予防又は治療剤 |
-
2006
- 2006-12-15 JP JP2007550244A patent/JP5107053B2/ja not_active Expired - Fee Related
- 2006-12-15 PL PL06834797T patent/PL1961420T3/pl unknown
- 2006-12-15 AU AU2006325947A patent/AU2006325947B2/en not_active Ceased
- 2006-12-15 ES ES06834797T patent/ES2393271T3/es active Active
- 2006-12-15 KR KR1020087016787A patent/KR101350226B1/ko not_active IP Right Cessation
- 2006-12-15 DK DK06834797.0T patent/DK1961420T3/da active
- 2006-12-15 CA CA2633481A patent/CA2633481C/en not_active Expired - Fee Related
- 2006-12-15 CN CN2006800466289A patent/CN101325952B/zh not_active Expired - Fee Related
- 2006-12-15 EP EP06834797A patent/EP1961420B1/en not_active Not-in-force
- 2006-12-15 WO PCT/JP2006/325054 patent/WO2007069727A1/ja active Application Filing
-
2008
- 2008-06-16 US US12/139,787 patent/US20080319038A1/en not_active Abandoned
-
2009
- 2009-05-18 HK HK09104504.2A patent/HK1126123A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2633481A1 (en) | 2007-06-21 |
| EP1961420A1 (en) | 2008-08-27 |
| CN101325952B (zh) | 2012-02-08 |
| KR101350226B1 (ko) | 2014-01-13 |
| AU2006325947A1 (en) | 2007-06-21 |
| WO2007069727A1 (ja) | 2007-06-21 |
| EP1961420A4 (en) | 2010-12-15 |
| ES2393271T3 (es) | 2012-12-19 |
| US20080319038A1 (en) | 2008-12-25 |
| CN101325952A (zh) | 2008-12-17 |
| KR20080097400A (ko) | 2008-11-05 |
| JPWO2007069727A1 (ja) | 2009-05-28 |
| JP5107053B2 (ja) | 2012-12-26 |
| HK1126123A1 (en) | 2009-08-28 |
| AU2006325947B2 (en) | 2011-09-01 |
| EP1961420B1 (en) | 2012-07-25 |
| CA2633481C (en) | 2013-12-17 |
| PL1961420T3 (pl) | 2012-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1961420T3 (da) | Middel til forebyggelse og behandling af akut nyresvigt | |
| DK1824475T3 (da) | Fremgangsmåde til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol | |
| DK2084151T3 (da) | Substituerede dihydropyrazoloner til behandling af kardiovaskulære og hæmatologiske sygdomme | |
| DK1877232T3 (da) | Fremgangsmåde til behandling af træoverflader | |
| DK3403657T3 (da) | Anvendelse af oligouronater til behandling af slimhyperviskositet | |
| DK3121169T3 (da) | Fremgangsmåder til syntese og/eller oprensning af diaminophenothiaziniumforbindelser | |
| DK2124999T3 (da) | Activin-actrii antagonister og anvendelser til behandling af anæmi | |
| DK2030476T3 (da) | Fremgangsmåde og system til forbedring af forståeligheden af lyde | |
| DK1685834T3 (da) | Anvendelse af pinolensyre til behandling af obesitet | |
| CY2200156T2 (el) | Επεξεργασια λυματων | |
| DE602006019395D1 (de) | Media-behandlungseinrichtung | |
| DK1928438T3 (da) | Anvendelse af ibudilast til behandling af stofafhængighed | |
| DK2177224T3 (da) | Forbindelse til forebyggelse og behandling af lidelser, som involverer modulation af RyR-receptorerne | |
| DK2518655T3 (da) | Anordning og fremgangsmåde til forebyggelse af hypoglykæmi | |
| DK1942898T3 (da) | Dipeptidylpeptidase-inhibitorer til behandling af diabetes | |
| NO20054709L (no) | Sammenfoyningssystem og anvendelse av dette | |
| DK2120604T3 (da) | Fremgangsmåde til fraktionering af havre, produkter derved opnået, og anvendelser deraf | |
| DK1948176T3 (da) | Diarylurinstoffer til behandling af pulmonær hypertension | |
| DK2079485T3 (da) | Phenylpropionamidforbindelser og anvendelsen deraf | |
| DK1802749T3 (da) | KASPP (LRRK2)-gen, dets fremstilling og anvendelse til påvisning og behandling af neurodegenerative lidelser | |
| DK3067068T3 (da) | Natrium-meta-arsenit til anvendelse i behandlingen af myelomatose | |
| DK1734959T3 (da) | Forbindelser til behandling af skizofreni og/eller glukoregulerende abnormaliteter | |
| DK1905452T3 (da) | Middel til forebyggelse eller behandling af glaukom | |
| DK1968574T3 (da) | Anvendelse af benzokondenserede heterocykliske sulfamidderivater til behandling af obesitet | |
| DK1896077T3 (da) | Fremgangsmåder og sammensætninger til forebyggelse og behandling af inflammatoriske sygdomme |